Ecstasy use: Cognitive deficits related to dosage rather than self-reported problematic use of the drug

Journal of Psychopharmacology

Volumn 15, Issue 4, 2001, Pages 273-281

  Fox, H C ^a   Parrott, A C ^a   Turner, J J D ^a  

^a UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

Drug use problems; Executive; MDMA; Memory; Neurotoxicity; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; CANNABIS; COCAINE; LYSERGIDE; NICOTINE; OPIATE; PSILOCYBINE; SOLVENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; FEMALE; HUMAN; MALE; MEMORY; NEUROPSYCHOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; REACTION TIME; SELF REPORT; SEROTONINERGIC SYSTEM; SPATIAL MEMORY; STRESS; TASK PERFORMANCE; WORKING MEMORY;

EID: 0035663512     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110101500406     Document Type: Article

References (46)

1. Neural systems engaged by planning: A PET study of the Tower of London task
2. Memory impairment in abstinent MDMA ('Ecstasy') users
3. Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity
4. Recall and recognition in mildly disturbed schizophrenics: The use of matched tasks
5. Computational approach to prefrontal cortex, cognitive control and schizophremia: Recent developments and current challenges
6. Prefrontal dysfunction in depressed pateints performing a complex planning task. A study using positron essimion tomography
7. Heavy MDMA ('Ecstasy') users: Selective performance deficits on the Cambridge Neuropsychological Test Automated Battery (CANTAB)
8. Differences in premorbid adjustment between problematic and nonproblematic Ecstasy users
9. Long-lasting effects of (+/-) 3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans
10. The circuitry of working memory revealed by anatomy and metabolic imaging
11. Impaired cognitive performance in drug-free recreational Ecstasy (MDMA) users
12. Chronic 3,4-methylenedioxymethamphetamine (mdma) use effects on mood and neuropsychological function
13. Thoughts on the relation between emotion and cognition
14. Aggression, suicidality and serotonin
15. Anxiety and the motivational basis of working memory
16. Neuropsychological consequences of extreme weight loss and dietry restriction in patients with anorexia nervosa
17. Positron emission tomography evidence of toxic effect of mdma ('Ecstasy') on brain serotonin neurones in human beings
18. Cognitive performance in 3,4-methylenedioxymethamphetamine (MDMA 'Ecstasy') users: A controlled study
19. Recreational drug use and pasychobiological problems. Collaborative UK/Italy Study (5): Ecstasy (MDMA) polydrug user findings
20. Memory deficits associated with recreational use of 'ecstasy' (MDMA)
21. Memory deficits persist for at least 6 months after abstinence from Ecstasy (MDMA)
22. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers
23. Uplifts, hassels, stresses and cognitive failures, in cigarette smokers and non smokers
24. Ecstasy (MDMA) effects upon mood and cognition: Before, during and after a Saturday night dance
25. Cognitive performance in recreational users of MDMA or ecstasy: Evidence for memory deficits
26. Methodologies and models in the study of executive function
27. Cognitive function following acute sleep restriction in children ages 10-14
28. (+/-) 3,4-methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: Studies in animals
29. Neurochemical alterations of serotonergic neuronal systems in depression
30. Prefrontal dysfunction in neuropsychiatric disorders - General discussion. Philosophical transactions of the Royal Society of London Series B
31. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analogue of the Wisconsin Card Sorting test: Possible interactions with subcortical dopamine
32. Cognitive performance amongst recreational users of 'ecstasy'
33. Mdma ('Ecstasy') consumption in the context of polydrug abuse: A report on 150 patients
34. Is the use of Ecstasy and hallucinogens increasing? Results from a community study
35. Specific impairments in planning
36. Recreational MDMA use in Sydney: A profile of ecstasy users and their experiences with the drug
37. Cognitive task performance profiles of current 'Ecstasy' (MDMA) users
38. Cognitive performance and serotonergic function in users of Ecstasy
39. Working memory deficits in current and previous users of MDMA ('Ecstasy')
40. Carbohydrate craving, mood changes and obesity